| Long name: |
Polyclonal Antibody to Endoglin (ENG) |
| Antigen: |
Endoglin (ENG) |
| Other names: |
CD105 antigen, Endoglin, N/A, endoglin, endoglin, endoglin isoform 1 |
| Gene name: |
ENG, Endoglin (ENG) |
| Gene synonims: |
END, END, ENG, HHT1, ORW1, ENG |
| Category: |
Antibodies |
| Clonality: |
Polyclonal Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Due to limitted amount of tested species we cannot guarantee that no crossreactivity will occur |
| Specificity: |
, ENG, It has been selected for its ability to recognize ENG in immunohistochemical staining andwestern blotting, The antibody is a rabbit polyclonal antibody raised against ENG, This is an antibody designed to detect Endoglin (ENG) |
| Purification method: |
This antibody was purified via Affinity Chromatography |
| Form/Appearance: |
containing 0, pH7, 02% NaN3, 4, 50% glycerol, Supplied as solution form in PBS |
| Concentration: |
2mg/ml |
| Storage, shipping and handling: |
Avoid cycles of freezing and thawing as they may denaturate the polypeptide chains of the antibody, Due to transportation or handling reasons, For longer periods of time we recommend keeping the vial frozen at -40 or -80, Upon receving, We recommend you to briefly cetrifuge the vial prior to use to gather the content on the bottom, freeze at -20, small amounts of the antibody might get caught on the lid or walls of the vial, The antibody is shipped at +4 degrees Celsius |
| Applications: |
EIA, ELI-Spot, ELISA, IFA, Immunohistochemistry (IHC) - Formalin/Paraffin, Western Blot (WB), Immunocytochemistry (ICC) |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
Endoglin (ENG) |
| Short name: |
Anti- Endoglin (ENG) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Antibody to Endoglin (endoglin) (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
DNA-templated and biological process this GO :0007155 and cell adhesion and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007507 and heart development and biological process this GO :0009897 and external side of plasma membrane and cellular component this GO :0009986 and cell surface and cellular component this GO :0010628 and positive regulation of gene expression and biological process this GO :0010862 and positive regulation of pathway-restricted SMAD protein phosphorylation and biological process this GO :0016477 and cell migration and biological process this GO :0017015 and regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0022009 and central nervous system vasculogenesis and biological process this GO :0022617 and extracellular matrix disassembly and biological process this GO :0030155 and regulation of cell adhesion and biological process this GO :0030336 and negative regulation of cell migration and biological process this GO :0030509 and BMP signaling pathway and biological process this GO :0030512 and negative regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0030513 and positive regulation of BMP signaling pathway and biological process this GO :0031953 and negative regulation of protein autophosphorylation and biological process this GO :0031960 and response to corticosteroid and biological process this GO :0032967 and positive regulation of collagen biosynthetic process and biological process this GO :0034713 and type I transforming growth factor beta receptor binding and molecular function this GO :0035556 and intracellular signal transduction and biological process this GO :0036273 and response to statin and biological process this GO :0042060 and wound healing and biological process this GO :0042127 and regulation of cell proliferation and biological process this GO :0042325 and regulation of phosphorylation and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0048185 and activin binding and molecular function this GO :0048745 and smooth muscle tissue development and biological process this GO :0048844 and artery morphogenesis and biological process this GO :0048845 and venous blood vessel morphogenesis and biological process this GO :0048870 and cell motility and biological process this GO :0050431 and transforming growth factor beta binding and molecular function this GO :0051001 and negative regulation of nitric-oxide synthase activity and biological process this GO :0060326 and cell chemotaxis and biological process this GO :0060348 and bone development and biological process this GO :0060394 and negative regulation of pathway-restricted SMAD protein phosphorylation and biological process this GO :0070022 and transforming growth factor beta receptor homodimeric complex and cellular component this GO :0070278 and extracellular matrix constituent secretion and biological process this GO :0070483 and detection of hypoxia and biological process this GO :0071260 and cellular response to mechanical stimulus and biological process this GO :0071559 and response to transforming growth factor beta and biological process this GO :0072563 and endothelial microparticle and cellular component, END and HHT1 and ORW1, ENG and IDBG-639059 and ENSBTAG00000008997 and 615844, ENG and IDBG-86582 and ENSG00000106991 and 2022, Eng and IDBG-160783 and ENSMUSG00000026814 and 13805, cytoplasmic mediator activity, cytoplasmic mediator activity and also this GO :0005114 : type II transforming growth factor beta receptor binding and also this GO :0005515 : protein binding and also this GO :0005534 : galactose binding and also this GO :0005539 : glycosaminoglycan binding and also this GO :0034713 : type I transforming growth factor beta receptor binding and also this GO :0042803 : protein homodimerization activity and also this GO :0048185 : activin binding and also this GO :0050431 : transforming growth factor beta binding, cytoplasmic mediator activity and molecular function this GO :0005114 and type II transforming growth factor beta receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005534 and galactose binding and molecular function this GO :0005539 and glycosaminoglycan binding and molecular function this GO :0005615 and extracellular space and cellular component this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0006355 and regulation of transcription, nuclei, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0001300 and chronological cell aging and biological process this GO :0001525 and angiogenesis and biological process this GO :0001569 and patterning of blood vessels and biological process this GO :0001570 and vasculogenesis and biological process this GO :0001666 and response to hypoxia and biological process this GO :0001934 and positive regulation of protein phosphorylation and biological process this GO :0001937 and negative regulation of endothelial cell proliferation and biological process this GO :0001947 and heart looping and biological process this GO :0003084 and positive regulation of systemic arterial blood pressure and biological process this GO :0003273 and cell migration involved in endocardial cushion formation and biological process this GO :0004888 and transmembrane signaling receptor activity and molecular function this GO :0005024 and transforming growth factor beta-activated receptor activity and molecular function this GO :0005072 and transforming growth factor beta receptor, this GO :0004888 : transmembrane signaling receptor activity, this GO :0004888 : transmembrane signaling receptor activity and also this GO :0005024 : transforming growth factor beta-activated receptor activity and also this GO :0005072 : transforming growth factor beta receptor, this GO :0005024 : transforming growth factor beta-activated receptor activity, this GO :0005072 : transforming growth factor beta receptor, this GO :0005114 : type II transforming growth factor beta receptor binding, this GO :0005515 : protein binding, this GO :0005534 : galactose binding, this GO :0005539 : glycosaminoglycan binding, this GO :0034713 : type I transforming growth factor beta receptor binding, this GO :0042803 : protein homodimerization activity, this GO :0048185 : activin binding, this GO :0050431 : transforming growth factor beta binding, transforming growth factor beta receptor, endoglin |
| Identity: |
3349 |
| Gene: |
ENG |
More about : ENG |
| Long gene name: |
endoglin |
| Synonyms gene: |
ORW1 ORW |
| Synonyms gene name: |
Osler-Rendu-Weber syndrome 1 |
| Synonyms: |
END HHT1 CD105 |
| Locus: |
9q34, 11 |
| Discovery year: |
1993-03-03 |
| GenBank acession: |
AF035753 |
| Entrez gene record: |
2022 |
| Pubmed identfication: |
8404038 10548503 |
| Classification: |
CD molecules |
| Havana BLAST/BLAT: |
OTTHUMG00000020723 |
| Locus Specific Databases: |
Hereditary Hemorrhagic Telangiectasia (HHT) Mutation Database LRG_589 |